• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

    45.02 +0.91 (+2.05%)
    Streaming Delayed Price Updated: 12:39 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 629,618
    Open 44.18
    Bid (Size) 45.01 (400)
    Ask (Size) 45.04 (100)
    Prev. Close 44.12
    Today's Range 43.81 - 46.36
    52wk Range 26.74 - 46.60
    Shares Outstanding 63,562,303
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biohaven Ltd. (BHVN): A High-Stakes Clinical Crossroad in Neuroscience and Immunology
    As of December 26, 2025, Biohaven Ltd. (NYSE: BHVN) finds itself at a critical juncture. Once the darling of the biotech sector following a staggering $11.6 billion acquisition of its migraine... 
    Via PredictStreet
    Topics Economy Intellectual Property
    News headline image
    Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares ↗
    Foresite Capital Goes Bullish on Cytokinetics (CYTK), Snapping Up 458K Shares 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +12.1%
    +12.1%
    1 Month
    +3.5%
    +3.5%
    3 Month
    +12.1%
    +12.1%
    6 Month
    +40.3%
    +40.3%
    1 Year
    +16.9%
    +16.9%

    More News

    Read More
    News headline image
    Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 3, 2025 ↗
    Via Benzinga
    News headline image
    Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? ↗
    Via The Motley Fool
    News headline image
    Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Present at Upcoming Investor Conferences
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Xenon Reports Third Quarter 2025 Financial Results & Business Update
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Insights into Xenon Pharmaceuticals's Upcoming Earnings ↗
    Via Benzinga
    News headline image
    Xenon to Report Q3 2025 Financial Results on November 3, 2025
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Design Therapeutics Appoints Justin Gover to Board of Directors
    From Design Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Reports Second Quarter 2025 Financial Results & Business Update
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
    Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
    What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
    Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
    The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
    What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
    The current price of Xenon Pharmaceuticals Inc. - Common Shares is 45.02
    When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
    The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 12/31/25 12:39 PM ET
    What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
    The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 2.86B
    How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
    Xenon Pharmaceuticals Inc. - Common Shares has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.